These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 20522382)
21. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131 [TBL] [Abstract][Full Text] [Related]
22. Long-term parotid gland function after radiotherapy. Braam PM; Roesink JM; Moerland MA; Raaijmakers CP; Schipper M; Terhaard CH Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):659-64. PubMed ID: 15936542 [TBL] [Abstract][Full Text] [Related]
23. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. Strigari L; Benassi M; Arcangeli G; Bruzzaniti V; Giovinazzo G; Marucci L Int J Radiat Oncol Biol Phys; 2010 May; 77(1):269-76. PubMed ID: 20100642 [TBL] [Abstract][Full Text] [Related]
24. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography. Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146 [TBL] [Abstract][Full Text] [Related]
25. Parotid dosimetric changes correlate to weight loss during radical but not adjuvant head and neck radiotherapy: an exploratory analysis. Chatterjee S; Sarkar S; Mahata A; Roy R; Achari R; Mallick I Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):685-6. PubMed ID: 23994039 [No Abstract] [Full Text] [Related]
26. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing. Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059 [TBL] [Abstract][Full Text] [Related]
27. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Hunt MA; Jackson A; Narayana A; Lee N Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):296-304. PubMed ID: 16904529 [TBL] [Abstract][Full Text] [Related]
28. [The sialographic aspect of the irradiated parotid gland]. Baroncelli G; Viviani G Radiol Med; 1967 Jun; 53(6):546-62. PubMed ID: 5188964 [No Abstract] [Full Text] [Related]
29. Bayesian generalized monotonic functional mixed models for the effects of radiation dose histograms on normal tissue complications. Schipper M; Taylor JM; Lin X Stat Med; 2007 Nov; 26(25):4643-56. PubMed ID: 17407198 [TBL] [Abstract][Full Text] [Related]
30. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia? You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607 [TBL] [Abstract][Full Text] [Related]
31. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Bhide S; Clark C; Harrington K; Nutting CM Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198 [TBL] [Abstract][Full Text] [Related]
32. Radiation-induced damage to microstructure of parotid gland: evaluation using high-resolution magnetic resonance imaging. Kan T; Kodani K; Michimoto K; Fujii S; Ogawa T Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1030-8. PubMed ID: 19879064 [TBL] [Abstract][Full Text] [Related]
33. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Gomez DR; Estilo CL; Wolden SL; Zelefsky MJ; Kraus DH; Wong RJ; Shaha AR; Shah JP; Mechalakos JG; Lee NY Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e207-13. PubMed ID: 21570202 [TBL] [Abstract][Full Text] [Related]
34. Xerostomia: a day and night difference. Dijkema T; Raaijmakers CP; Braam PM; Roesink JM; Monninkhof EM; Terhaard CH Radiother Oncol; 2012 Aug; 104(2):219-23. PubMed ID: 22809589 [TBL] [Abstract][Full Text] [Related]
35. Influence of the linac design on intensity-modulated radiotherapy of head-and-neck plans. Topolnjak R; van der Heide UA; Meijer GJ; van Asselen B; Raaijmakers CP; Lagendijk JJ Phys Med Biol; 2007 Jan; 52(1):169-82. PubMed ID: 17183134 [TBL] [Abstract][Full Text] [Related]
36. The effect of local radiotherapy on kallikrein activity in saliva secreted by parotid gland in patients with head and neck cancers. CzokaĆo M; Silko J; Topczewska E Rocz Akad Med Bialymst; 1996; 41(2):441-51. PubMed ID: 9020557 [TBL] [Abstract][Full Text] [Related]
37. Comments on the use of the Lyman-Kutcher-Burman model to describe tissue response to nonuniform irradiation. Deasy JO Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1458-60. PubMed ID: 10939885 [No Abstract] [Full Text] [Related]
38. Parotid sialometry--a functional study of the parotid gland in pre- and post-irradiation head and neck cancers. Dutta TK; Bhattacharjee TK; Gupta BD; Popli SP Indian J Med Sci; 1973 Jun; 27(6):461-4. PubMed ID: 4756224 [No Abstract] [Full Text] [Related]
39. Time course and significance of acute hyperamylasemia in patients receiving fractionated therapeutic radiation to the parotid gland region. Borok TL; Cooper JS Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1449-51. PubMed ID: 6183243 [TBL] [Abstract][Full Text] [Related]
40. Radiosensitivity of the human parotid gland. Shannon IL; Trodahl JN; Starcke EN Proc Soc Exp Biol Med; 1978 Jan; 157(1):50-3. PubMed ID: 622373 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]